Q3 2023 Holdings
Filed 2023-11-14 | 83 holdings | $2.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $109.1M | 2,065,800 | 4.4% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $103.2M | 797,500 | 4.2% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $74.1M | 286,800 | 3.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $73.4M | 652,100 | 3.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $72.3M | 166,300 | 2.9% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $65.0M | 967,000 | 2.6% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $63.5M | 963,800 | 2.6% |
| The Cigna Group(CI) | COM | 125523100 | $59.4M | 207,700 | 2.4% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $57.9M | 2,144,971 | 2.3% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $56.6M | 112,200 | 2.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $54.5M | 450,000 | 2.2% |
| Humana Inc(HUM) | COM | 444859102 | $53.7M | 110,300 | 2.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $51.4M | 2,614,960 | 2.1% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $50.3M | 715,000 | 2.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $48.5M | 286,700 | 2.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $47.7M | 58,000 | 1.9% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $45.6M | 262,100 | 1.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $45.1M | 1,173,662 | 1.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $44.3M | 777,172 | 1.8% |
| Danaher Corporation(DHR) | COM | 235851102 | $43.8M | 176,600 | 1.8% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $42.1M | 2,100,000 | 1.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $41.7M | 801,100 | 1.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $41.0M | 2,821,000 | 1.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $40.3M | 75,000 | 1.6% |
| Natera Inc(NTRA) | COM | 632307104 | $39.8M | 899,000 | 1.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $39.6M | 80,600 | 1.6% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $39.1M | 1,338,000 | 1.6% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $38.8M | 558,400 | 1.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $38.5M | 756,165 | 1.6% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $37.7M | 751,600 | 1.5% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $37.4M | 739,100 | 1.5% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $36.1M | 1,142,850 | 1.5% |
| Privia Health Group Inc(PRVA) | COM | 74276R102 | $35.5M | 1,545,100 | 1.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $35.2M | 377,700 | 1.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $33.4M | 1,285,400 | 1.3% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $32.5M | 1,587,429 | 1.3% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $32.2M | 1,756,940 | 1.3% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $30.4M | 1,917,907 | 1.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $29.7M | 115,400 | 1.2% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $28.9M | 6,050,212 | 1.2% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $28.6M | 1,063,897 | 1.2% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $28.2M | 114,800 | 1.1% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $25.4M | 1,800,000 | 1.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $25.2M | 500,000 | 1.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $22.9M | 182,000 | 0.9% |
| Curevac N V | COM | N2451R105 | $21.3M | 3,116,100 | 0.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $20.7M | 296,800 | 0.8% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $19.4M | 544,000 | 0.8% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $18.4M | 382,305 | 0.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $18.2M | 657,200 | 0.7% |